|Mr. John G. Melo||Pres, CEO & Director||1.8M||N/A||1966|
|Ms. Kathleen Valiasek||Chief Financial Officer||615.47k||N/A||1964|
|Mr. Eduardo Alvarez||Chief Operating Officer||534.26k||N/A||1964|
|Ms. Nicole Kelsey||Gen. Counsel & Sec.||704.16k||N/A||1967|
|Dr. Joel R. Cherry||Pres of R&D||N/A||N/A||1961|
Amyris, Inc., an integrated renewable products company, delivers alternatives to petroleum, plant, and animal-based products across a range of consumer and industry segments worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products. The company delivers its No Compromise products and services in markets, such as specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Amyris, Inc.’s ISS Governance QualityScore as of April 1, 2019 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 7; Compensation: 9.